Evidence map›Paper›PMID 35354854›Full record

ArticleScientific reports2022

Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples.

Yi-Chan Lin, Rebecca J Malott, Linda Ward, Linet Kiplagat, Kanti Pabbaraju, Kara Gill, Byron M Berenger, Jia Hu, Kevin Fonseca, Ryan S Noyce and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Insights from respiratory virus co-infections.World journal of virology · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yi-Chan LinDepartment of Medical Microbiology and Immunology, University of Alberta, 6-142L Katz Group Centre, Edmonton, AB, T6G 2J7, Canada.
Rebecca J MalottCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Linda WardCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Linet KiplagatCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Kanti PabbarajuAlberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, AB, Canada.
Kara GillAlberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, AB, Canada.
Byron M BerengerCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Jia HuCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Kevin FonsecaCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
Ryan S NoyceDepartment of Medical Microbiology and Immunology, University of Alberta, 6-142L Katz Group Centre, Edmonton, AB, T6G 2J7, Canada.
Thomas LouieCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.
David H EvansDepartment of Medical Microbiology and Immunology, University of Alberta, 6-142L Katz Group Centre, Edmonton, AB, T6G 2J7, Canada. devans@ualberta.ca.ORCID http://orcid.org/0000-0001-5871-299X
John M ConlyCumming School of Medicine, University of Calgary, 3030 Hospital Dr NW, Calgary, AB, T2N 4W4, Canada.ORCID http://orcid.org/0000-0002-3348-0157

Funding

CIHR
6 · The paper itself

Abstract

To explore the potential modes of Severe Acute Respiratory Coronavirus-2 (SARS-CoV-2) transmission, we collected 535 diverse clinical and environmental samples from 75 infected hospitalized and community patients. Infectious SARS-CoV-2 with quantitative burdens varying from 5 plaque-forming units/mL (PFU/mL) up to 1.0 × 10

Indexed as

COVID-19HumansPolymerase Chain ReactionRespiratory SystemSARS-CoV-2

Identifiers

PMID35354854
PMCPMC8967087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.